Recruiting for Research Study: THRIVE (Targeting Health and Resilience for Individuals with a Vulnerable Eating History)
Do you have a history of an eating disorder or eating problems and are currently in your first or second trimester of pregnancy?
Research from the CWMH: Prenatal Exposure to Second Generation Antipsychotics and Neurodevelopmental Outcomes in Preschool-Aged Children
The current study observed no significant differences in overall developmental outcomes or behavior in exposed versus unexposed children.
New Research from the CWMH: Risk of Major Malformations in Infants with Prenatal Exposure to Benzodiazepines
Data from an ongoing pregnancy registry offers reassurance that benzodiazepines do not appear to have major teratogenic effects.
Recruiting for Research Study: Pregnenolone Neurosteroid for Menopausal Depression
As of October 2023, the Neurosteroid Intervention for Menopausal and Perimenopausal Depression is no longer recruiting participants. Over the last few years we have heard a great deal about neurosteroids, also known as neuroactive steroids. [...]
New Research from the CWMH: More Data on the Reproductive Safety of Lurasidone and Quetiapine
New findings from the National Pregnancy Registry for Atypical Antipsychotics provide reassuring data regarding the safety of prenatal exposure to lurasidone and quetiapine in a sample of well-characterized participants.
New Research at the Center for Women’s Mental Health: The MGH Postpartum Psychosis Project
Although the last decade has brought increased awareness of and interest in postpartum mood and anxiety disorders, our understanding of the etiology of this most severe form of postpartum mental illness remains elusive.
New Research from the CWMH: No Increase in Major Malformations in Children with Prenatal Exposure to Olanzapine
No major malformations were associated with olanzapine exposure during the first trimester of pregnancy.
New Research from the CWMH: Preliminary Data on the Reproductive Safety of Buspirone (BuSpar)
Although a small sample, no major malformations were observed in a prospectively followed cohort of women with first trimester exposure to buspirone.
New Research Study at the CWMH: A Novel Treatment for Menopausal Depression
The transition to menopause, or perimenopause, represents the passage from reproductive to non-reproductive life. During the perimenopause, women experience irregular menstrual cycles, which reflect the large fluctuations in ovarian hormone [...]
Research from the CWMH: Screening for Postpartum Depression, Treatment Engagement, Barriers to Care
Further systematic research on outcomes after postpartum screening is needed to ensure that screening translates into improved clinical outcomes.